Trump administration
-
White House App Promotes Trump’s Record, Omits Key Details
The White House launched a new app showcasing President Trump’s second-term achievements and favorable news, featuring updates “straight from the source.” It highlights policy priorities, economic affordability data, and healthcare cost reductions, though data presentation is selective. The app also includes a feature for submitting tips to ICE and omits rising prices of certain goods and oil. Claims of live streaming capabilities are also questionable.
-
Anthropic Secures Preliminary Injunction Against Trump DoD
A federal judge has granted AI startup Anthropic a preliminary injunction against the Trump administration’s blacklisting, pausing the Pentagon’s designation of Anthropic as a supply chain risk. The ruling effectively allows Anthropic to continue its work with federal agencies while litigation proceeds. The judge criticized the administration’s actions as illegal First Amendment retaliation, stating the government’s stance was an “Orwellian notion.” Anthropic expressed gratitude and a commitment to working productively with the government.
-
Trump Approves Nvidia H200 Sales to China Amidst 25% Surcharge
The Trump administration has approved sales of Nvidia’s H200 AI chips to China, while also imposing a 25% tariff on these transactions. This move permits competition for Nvidia and other U.S. chip companies in the significant Chinese market, with the U.S. government set to collect revenue through tariffs. The decision comes with conditions to ensure U.S. supply and security, and follows Nvidia’s confirmation of high demand for the H200 from Chinese customers.
-
AbbVie and Trump Administration Forge Deal on American Drug Access and Affordability
AbbVie has reached a landmark deal with the Trump administration, committing billions to U.S. R&D and capital investments over a decade. The agreement includes lower prices for Medicaid beneficiaries and expanded direct-to-patient access through “TrumpRx.” This pact, exempting AbbVie from tariffs and future price mandates, aims to balance domestic investment with drug affordability, supporting innovation and patient access.
-
Tesla’s Fate in the Balance: Trump’s Policies Spur GM, Ford EV Retreat
GM’s projected $1.6B charge on EV investments signals growing EV strategy concerns among legacy automakers, compounded by the sunsetting of federal tax credits under President Trump. Tesla’s market share is declining amidst increased competition, despite leading in sales volume. As traditional automakers pull back, Tesla might benefit, but overall EV demand is expected to shrink. Musk is shifting focus to robotaxis and humanoid robotics. Analysts anticipate slowing revenue growth for Tesla, highlighting the impact of policy changes and market shifts.
-
Trump’s H-1B Visa Reforms: A Blow to Startups?
The US tech sector faces uncertainty due to potential immigration policy changes, specifically a proposed $100,000 fee on new H-1B visa sponsorships. This could disproportionately impact startups and limit access to crucial global talent. While some, like Netflix’s Reed Hastings, see benefits in prioritizing higher-skilled roles, concerns persist about incentivizing talent to seek opportunities elsewhere and the negative impact on US innovation and competitiveness. Experts warn that the changes could benefit competitors like China and hinder the ability of companies to recruit and compete.
-
US Government Revokes Harvard’s International Student Admissions Authority – Mandates Transfers for Current Enrollees
The Trump administration revoked Harvard’s certification to enroll international students, alleging “terrorism support,” forcing 6,800 current students to transfer or face legal status risks. The move impacts Harvard’s $5.4B budget, as international students (27% of its body) pay full tuition. Officials framed it as accountability for defying federal demands on curriculum and campus policies. Harvard, which had sued to reclaim $2.2B in frozen grants, called the action unlawful overreach threatening U.S. academic leadership. A federal judge issued a temporary restraining order blocking enforcement, setting up prolonged legal battles. The conflict highlights tensions between federal authority and higher education autonomy.